Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...

The challenge for Bayer will be carving out a role for Kerendia in mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF) heart failure alongside SGLT2 inhibitors – AstraZeneca's Farxiga ...

Eagle, MD, MACC. New Research Explores Benefits of Finerenone in Patients With HFmrEF or HFpEF; More In patients with heart failure (HF) and mildly reduced or preserved ejection fraction (HFmrEF/HFpEF ...

During ESC Congress 2024, initial results from FINEARTS-HF found finerenone lowered the total risk of worsening HF events and death from cardiovascular causes among roughly 6,000 patients with HFmrEF ...

Integrating GLP-1 therapies with lifestyle factors and nutrition counseling is essential for optimal outcomes in patients with HFpEF. Stay at the forefront of Med School & Residency — REGISTER ...

BOSTON, MA—Tirzepatide improves outcomes in patients with heart failure with preserved ejection fraction (HFpEF) and obesity, no matter how much excess body weight they have, according to an analysis ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight into the natural history and pathophysiology of this complex syndrome, thereby allowing ...

View all available purchase options and get full access to this article.

High-quality mechanistic and clinically relevant science to keep clinicians at the forefront of the latest advancements in the diagnosis and treatment of heart failure ...